Latest Research

Mindfulness-Based Intervention for Patients with Generalized Anxiety Disorder: A Randomized Controlled Trial (Zhang et al., 2026)

(Zhang et al., 2026)

Hands wrapped around a warm cup of tea, with a cream knitted sleeve
Photo by Kelly Sikkema on Unsplash

Generalized anxiety disorder, marked by persistent and hard-to-control worry, is usually treated with medication, yet many people continue to struggle even when the dose is stable. Mindfulness programs have been proposed as an add-on, but good-quality trials in people with this diagnosis remain limited. A team at Tianjin Anding Hospital in China, led by Cancan Zhang and Lei Sun, tested the idea in a randomized trial reported in Frontiers in Psychiatry.

The study enrolled 106 adults aged 18 to 65 who met diagnostic criteria for the disorder, had moderate-to-severe anxiety on a clinician-rated scale, and had been on a steady dose of medication, mostly SSRI antidepressants, for at least six weeks. Half were randomly assigned to an eight-week group program adapted from mindfulness-based cognitive therapy, with weekly sessions of two to two and a half hours led by trained clinical psychologists, plus 30 to 45 minutes of daily practice at home. The other half joined an active comparison program of eight weekly one-hour sessions on anxiety education, sleep habits, stress management and lifestyle advice, with no mindfulness or cognitive behavioural techniques. Everyone kept taking their medication, and the people rating symptoms and the statistician did not know who had received which program.

Right after the programs ended, clinician-rated anxiety was lower in the mindfulness group, averaging about 19 points on the scale against about 22 in the comparison group, a moderate difference. Importantly, this gap appeared on top of medication and against a comparison that also offered support and attention. Self-rated anxiety showed a similar pattern. The mindfulness group also reported better sleep, less of the threat-focused thinking that tends to accompany anxiety, higher mindfulness skills and better everyday functioning. The authors suggest that learning to notice worry without being carried along by it may underlie these changes, but they did not measure the mechanism, for instance with brain imaging or statistical tests of mediation.

Several cautions apply. Outcomes were measured only straight after the programs, so it is unknown whether the benefits last or protect against relapse. The trial took place at a single hospital, medication types and doses were not standardized, and neither participants nor therapists could be unaware of which program they were in, which may have shaped self-reports. Sleep was assessed by questionnaire alone, and the article does not report how many sessions people attended or how much they practised at home, details that would show how much practice is needed.

Taken together, the findings add to evidence that mindfulness can be a useful companion to medication for people with generalized anxiety, rather than a replacement for it. Larger multi-site trials with longer follow-up and records of attendance and home practice will be needed to show who benefits most and for how long.

Reference and link: https://doi.org/10.3389/fpsyt.2026.1810049